Organization
Nagasaki University, Nagasaki, Japan
3 abstracts
Abstract
Expression molecular subtype as a predictor of outcomes of chemoradiotherapy for esophageal cancer.Org: Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, Clinical Trial Promotion Department, Chiba Cancer Center, Chiba City, Chiba, Japan, Department of Gastroenterology and Endoscopy, National Cancer Center Hospital East, Kashiwa, Japan, Department of Clinical Trial Promotion, Chiba Cancer Center, Chiba, Japan, Osaka International Cancer Institute, Osaka, Japan,
Abstract
A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PEFICITINIB (ASP015K) IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAD AN INADEQUATE RESPONSE TO METHOTREXATEOrg: Keio University, Tokyo, Japan, University of Occupational and Environmental Health, Kitakyushu, Japan, University of Tokyo, Tokyo, Japan, Nagasaki University, Nagasaki, Japan, Yokohama City University, Yokohama, Japan,
Abstract
A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PEFICITINIB (ASP015K) IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAD AN INADEQUATE RESPONSE TO DMARDSOrg: University of Occupational and Environmental Health, Kitakyushu, Japan, Keio University, Tokyo, Japan, University of Tokyo, Tokyo, Japan, Nagasaki University, Nagasaki, Japan, Yokohama City University, Yokohama, Japan,